National Institute for Health and Care Research logo
National Institute for Health and Care Research

Reconstruction surgery for FGM/C survivors

Funds a UK trial on the benefits and harms of reconstructive surgery for FGM/C survivors.

This is a single-stage funding opportunity: applicants submit one full application rather than an outline followed by a full stage. The independent funding committee reviews the written application and also interviews shortlisted teams in a central London location. Funding is staged in two phases: an initial feasibility study that tests whether participants can be recruited and randomised, followe

The HTA Programme wants a study exploring the potential benefits and harms of reconstructive surgery for survivors of female genital mutilation/cutting, alongside the role of psychosexual counselling for women considering that surgery. This responds to a specific evidence gap: NHS England currently offers deinfibulation but not clitoral reconstruction or similar procedures, due to a lack of high-quality trial evidence. Applicants must design the trial themselves within this single named research question.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.12 Nov 2026
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
European Commission logo
Open

Horizon Cancer Mission: Mental Health for Young Survivors

🇪🇺European Commission · European Union

Funds a €7M platform giving adolescent and young adult cancer patients and survivors personalized digital tools for coping and psychological support.

Medtech
€7MSep'26
European Commission logo
Scheduled

Young Cancer Survivors Quality of Life Network

🇪🇺European Commission · European Union

Funds one €3M coordination action that helps cancer charities and funders improve quality of life for young survivors across Europe.

MedtechBiotech+1
€3MSep'27
European Commission logo
Scheduled

Clinical Research for Common Cancers

🇪🇺European Commission · European Union

Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.

MedtechBiotech+1
€7M – €10MSep'27
European Commission logo
Scheduled

Access to Research Infrastructure Services for EU Priorities and Emerging Challenges

🇪🇺European Commission · European Union

Funds €6M consortia that open Europe’s best research infrastructures to challenge-driven users and EU priorities.

MedtechAgritech+2
€6MJun'27
European Commission logo
Scheduled

Cancer Mission: First-in-Human Trials for Rare Cancers

🇪🇺European Commission · European Union

Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.

BiotechMedtech+1
€7M – €9MSep'27
European Commission logo
Scheduled

Mission Soil and Cancer: Living Labs for Carcinogenic Contamination

🇪🇺European Commission · European Union

Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.

Climate TechMedtech+2
€12MSep'27